115 related articles for article (PubMed ID: 2709617)
1. [Effects of prophylactically used latamoxef with tobramycin against postoperative infections on therapeutic drug monitoring and renal function in the field of obstetrics and gynecology].
Chimura T; Hirayama T; Ogawa T; Shiina Y
Jpn J Antibiot; 1989 Jan; 42(1):189-92. PubMed ID: 2709617
[TBL] [Abstract][Full Text] [Related]
2. [Prophylactic effects of a combined use of a cephem antibiotic, latamoxef, and tobramycin on postoperative infection in obstetrics and gynecology].
Chimura T; Sato S; Suzuki T; Ito K; Sumiyoshi Y; Kanasugi H; Nakakuki M; Abe Y; Banzai M
Jpn J Antibiot; 1987 Jul; 40(7):1253-8. PubMed ID: 3682180
[TBL] [Abstract][Full Text] [Related]
3. [Comparative nephrotoxicity of latamoxef and other cephalosporins in rabbits. Combined administration with furosemide or tobramycin. (author's transl)].
Harada Y; Teshima K; Okamoto T
Jpn J Antibiot; 1981 Dec; 34(12):1549-70. PubMed ID: 6460885
[TBL] [Abstract][Full Text] [Related]
4. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (4). Effects of tobramycin alone and in combination with latamoxef on the stability of rat kidney lysosomal membranes.
Kojima R; Ito M; Suzuki Y
Jpn J Pharmacol; 1987 Jan; 43(1):73-80. PubMed ID: 3573418
[TBL] [Abstract][Full Text] [Related]
5. [Studies on tobramycin by the intravenous drip infusion method].
Okada K; Kawamura N; Ohkoshi M; Oda T; Ikeda N; Nemoto S
Jpn J Antibiot; 1984 Apr; 37(4):605-14. PubMed ID: 6471381
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluations of tobramycin in treatment of chronic complicated urinary tract infections by intravenous drip infusion administration (author's transl)].
Suzuki K
Jpn J Antibiot; 1982 Feb; 35(2):409-20. PubMed ID: 7087177
[TBL] [Abstract][Full Text] [Related]
7. [Clinical studies on tobramycin using intravenous drip infusion (author's transl)].
Saito A; Kikuiri T; Tomizawa M; Ujiie A; Kinoshita Y
Jpn J Antibiot; 1981 Sep; 34(9):1255-62. PubMed ID: 7328750
[TBL] [Abstract][Full Text] [Related]
8. [Clinical application of latamoxef during the perinatal period].
Cho N; Suzuki H; Akiyama T; Kawamura E; Togo M; Nishimoto S; Hidaka T; Fukunaga K; Kunii K
Jpn J Antibiot; 1983 Sep; 36(9):2395-404. PubMed ID: 6655858
[TBL] [Abstract][Full Text] [Related]
9. [Fundamental and clinical studies on tobramycin by intravenous drip infusion (author's transl)].
Toyonaga Y; Kurosu Y; Hori M
Jpn J Antibiot; 1981 Nov; 34(11):1436-46. PubMed ID: 7334577
[TBL] [Abstract][Full Text] [Related]
10. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (3). Protective effect of latamoxef against tobramycin nephrotoxicity and its protective mechanism.
Kojima R; Ito M; Suzuki Y
Jpn J Pharmacol; 1986 Nov; 42(3):397-404. PubMed ID: 3820859
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of latamoxef, an oxacephem antibiotic with special reference to transport of latamoxef into the lung tissues and prevention of postoperative infections after thoracotomy].
Imaizumi M; Kimura J; Akiyama S; Uchida T; Ichimura I; Hirai K; Kawahara K; Kondo T
Jpn J Antibiot; 1983 Aug; 36(8):2081-92. PubMed ID: 6655826
[TBL] [Abstract][Full Text] [Related]
12. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (6): A mechanism for the suppressive action of latamoxef on intrarenal tobramycin level.
Kojima R; Ito M; Suzuki Y
Jpn J Pharmacol; 1990 May; 53(1):111-20. PubMed ID: 2352376
[TBL] [Abstract][Full Text] [Related]
13. [Experimental and clinical evaluation latamoxef in newborn and premature infants].
Toyonaga Y; Kurosu Y; Sugita M; Kitagawa M; Hori M
Jpn J Antibiot; 1983 Sep; 36(9):2322-35. PubMed ID: 6655851
[TBL] [Abstract][Full Text] [Related]
14. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects. (5). Interaction of tobramycin with latamoxef in vitro.
Kojima R; Ito M; Suzuki Y
J Pharmacobiodyn; 1988 Jan; 11(1):9-17. PubMed ID: 3385606
[TBL] [Abstract][Full Text] [Related]
15. [Laboratory and clinical studies on latamoxef in the field of obstetrics and gynecology].
Takase Z; Shirafuji H; Matsuda S; Tanno M; Kashiwakura T; Cho N; Fukunaga K; Kunii K; Hogaki M; Muronosono E; Matsumoto Y; Tabei T; Hayashi S; Nakamura H; Seki K; Fukuda T; Aoyama S; Kurasawa S; Ninomiya K; Hiraoka O; Nakai T; Shimizu H; Sugimoto O; Kamiyoshi S; Watanabe K; Fujimoto A; Doi S; Jujii K; Yamada F; Ozawa M; Shimizu T; Risai T; Morimoto N; Kobayashi H; Kondo I; Saita K; Ibaragi K; Kamigawara Y; Sawaragi I; Yuasa M; Hirabayashi K; Okada E; Shirakawa K; Oniki K; Yamamoto K; Yamabe T; Motomura R; Nakanishi K; Teramoto C; Haraguchi H
Jpn J Antibiot; 1983 Jan; 36(1):1-15. PubMed ID: 6221127
[TBL] [Abstract][Full Text] [Related]
16. [Postoperative changes in amount of granulocyte-elastase, alpha 1-antitrypsin and other acute phase reactants in blood in obstetrical and gynecological patients].
Chimura T; Morisaki N; Saitoh N
Jpn J Antibiot; 1989 Sep; 42(9):1863-7. PubMed ID: 2478731
[TBL] [Abstract][Full Text] [Related]
17. [The prophylactic effects of latamoxef against the postoperative infections to open heart surgery. Studies on the penetration of latamoxef into the pericardial fluid and the auricle of heart].
Matsuura Y; Tamura M; Yamashina H; Higo M; Fujii T; Yamamoto M; Shimamoto H; Yamada H; Oguma T; Shimamura K
Jpn J Antibiot; 1986 May; 39(5):1241-9. PubMed ID: 3761554
[TBL] [Abstract][Full Text] [Related]
18. Empirical treatment of febrile, neutropenic patients with tobramycin and latamoxef.
Rhodes EG; Harris RI; Welch RS; Perry DJ; Brown RM; Boughton BJ
J Hosp Infect; 1987 May; 9(3):278-84. PubMed ID: 2886533
[TBL] [Abstract][Full Text] [Related]
19. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (7): Effect of latamoxef on binding of tobramycin to brush border membranes isolated from rat kidney cortex.
Kojima R; Ito M; Suzuki Y
Jpn J Pharmacol; 1989 Dec; 51(4):465-73. PubMed ID: 2615039
[TBL] [Abstract][Full Text] [Related]
20. [Clinical studies on tobramycin for infectious diseases following intravenous drip infusion (author's transl)].
Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E; Kasai Y; Nakanishi M; Katoh H; Matsuda S
Jpn J Antibiot; 1981 Aug; 34(8):1158-72. PubMed ID: 7321194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
